Caris Life Sciences, Inc. (CAI)
NASDAQ: CAI · Real-Time Price · USD
30.08
-1.09 (-3.50%)
Oct 31, 2025, 4:00 PM EDT - Market closed
Caris Life Sciences Market Cap
Caris Life Sciences has a market cap or net worth of $8.46 billion as of October 31, 2025.
Market Cap
8.46B
Enterprise Value
8.16B
1-Year Change
n/a
Ranking
Category
Stock Price
$30.08
Market Cap Chart
Since the IPO on June 18, 2025, Caris Life Sciences's market cap has increased from $5.95B to $8.46B, an increase of 42.06%. That is a compound annual growth rate of 158.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 8.46B | -3.50% |
| Oct 30, 2025 | 8.77B | 5.91% |
| Oct 29, 2025 | 8.28B | -3.13% |
| Oct 28, 2025 | 8.54B | 0.43% |
| Oct 27, 2025 | 8.51B | -2.64% |
| Oct 24, 2025 | 8.74B | -1.86% |
| Oct 23, 2025 | 8.90B | 5.39% |
| Oct 22, 2025 | 8.45B | -4.73% |
| Oct 21, 2025 | 8.87B | 0.10% |
| Oct 20, 2025 | 8.86B | - |
| Oct 17, 2025 | 8.86B | -1.41% |
| Oct 16, 2025 | 8.99B | 2.54% |
| Oct 15, 2025 | 8.76B | 2.64% |
| Oct 14, 2025 | 8.54B | 0.33% |
| Oct 13, 2025 | 8.51B | -0.72% |
| Oct 10, 2025 | 8.57B | -2.50% |
| Oct 9, 2025 | 8.79B | -5.13% |
| Oct 8, 2025 | 9.27B | 4.34% |
| Oct 7, 2025 | 8.88B | -3.75% |
| Oct 6, 2025 | 9.23B | 3.24% |
| Oct 3, 2025 | 8.94B | 6.97% |
| Oct 2, 2025 | 8.36B | -2.04% |
| Oct 1, 2025 | 8.53B | 0.26% |
| Sep 30, 2025 | 8.51B | 0.83% |
| Sep 29, 2025 | 8.44B | 2.77% |
| Sep 26, 2025 | 8.21B | -1.82% |
| Sep 25, 2025 | 8.36B | -2.33% |
| Sep 24, 2025 | 8.56B | -5.17% |
| Sep 23, 2025 | 9.03B | -2.55% |
| Sep 22, 2025 | 9.26B | 1.10% |
| Sep 19, 2025 | 9.16B | -2.54% |
| Sep 18, 2025 | 9.40B | -0.30% |
| Sep 17, 2025 | 9.43B | -0.39% |
| Sep 16, 2025 | 9.47B | 1.63% |
| Sep 15, 2025 | 9.31B | -2.76% |
| Sep 12, 2025 | 9.58B | -0.44% |
| Sep 11, 2025 | 9.62B | 2.43% |
| Sep 10, 2025 | 9.39B | -1.62% |
| Sep 9, 2025 | 9.55B | -2.47% |
| Sep 8, 2025 | 9.79B | -0.11% |
| Sep 5, 2025 | 9.80B | -4.13% |
| Sep 4, 2025 | 10.22B | -1.22% |
| Sep 3, 2025 | 10.35B | 0.66% |
| Sep 2, 2025 | 10.28B | -4.77% |
| Aug 29, 2025 | 10.80B | 0.42% |
| Aug 28, 2025 | 10.75B | 0.03% |
| Aug 27, 2025 | 10.75B | -0.44% |
| Aug 26, 2025 | 10.80B | -0.23% |
| Aug 25, 2025 | 10.82B | -2.09% |
| Aug 22, 2025 | 11.05B | 3.10% |
| Aug 21, 2025 | 10.72B | 8.70% |
| Aug 20, 2025 | 9.86B | -5.04% |
| Aug 19, 2025 | 10.39B | 2.73% |
| Aug 18, 2025 | 10.11B | -1.51% |
| Aug 15, 2025 | 10.26B | -1.32% |
| Aug 14, 2025 | 10.40B | 7.91% |
| Aug 13, 2025 | 9.64B | 5.61% |
| Aug 12, 2025 | 9.13B | 8.72% |
| Aug 11, 2025 | 8.40B | 1.55% |
| Aug 8, 2025 | 8.27B | 4.06% |
| Aug 7, 2025 | 7.95B | -1.24% |
| Aug 6, 2025 | 8.05B | -4.46% |
| Aug 5, 2025 | 8.42B | 2.75% |
| Aug 4, 2025 | 8.20B | 5.17% |
| Aug 1, 2025 | 7.79B | -0.14% |
| Jul 31, 2025 | 7.80B | -4.81% |
| Jul 30, 2025 | 8.20B | 7.19% |
| Jul 29, 2025 | 7.65B | 1.70% |
| Jul 28, 2025 | 7.52B | -8.40% |
| Jul 25, 2025 | 8.21B | 0.17% |
| Jul 24, 2025 | 8.20B | -1.80% |
| Jul 23, 2025 | 8.35B | -0.86% |
| Jul 22, 2025 | 8.42B | 7.07% |
| Jul 21, 2025 | 7.86B | -6.29% |
| Jul 18, 2025 | 8.39B | -3.50% |
| Jul 17, 2025 | 8.70B | -0.37% |
| Jul 16, 2025 | 8.73B | 8.61% |
| Jul 15, 2025 | 8.04B | 4.29% |
| Jul 14, 2025 | 7.70B | 4.56% |
| Jul 11, 2025 | 7.37B | -0.41% |
| Jul 10, 2025 | 7.40B | -2.28% |
| Jul 9, 2025 | 7.57B | 3.61% |
| Jul 8, 2025 | 7.31B | -0.90% |
| Jul 7, 2025 | 7.37B | -0.04% |
| Jul 3, 2025 | 7.38B | -0.67% |
| Jul 2, 2025 | 7.43B | 0.79% |
| Jul 1, 2025 | 7.37B | -0.79% |
| Jun 30, 2025 | 7.43B | -0.34% |
| Jun 27, 2025 | 7.45B | 0.22% |
| Jun 26, 2025 | 7.43B | 1.21% |
| Jun 25, 2025 | 7.35B | -4.58% |
| Jun 24, 2025 | 7.70B | 6.78% |
| Jun 23, 2025 | 7.21B | -4.81% |
| Jun 20, 2025 | 7.57B | 27.19% |
| Jun 18, 2025 | 5.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 758.14B |
| Johnson & Johnson | 455.48B |
| AbbVie | 403.13B |
| UnitedHealth Group | 312.23B |
| AstraZeneca | 255.76B |
| Novartis AG | 236.67B |
| Novo Nordisk | 222.08B |
| Abbott Laboratories | 216.98B |